Moreover, PD-L1 and B7-H3 blocked the negated tumor-promoting efficacy induced by the miR-326 inhibitor; hence, an improved antitumor immunity is mediated by PD-L1/B7-H3. This evidence concerns the gene CD274 and neoplasm.